Background and Aims. Villin is a highly specialised protein and is expressed in intestinal and renal proximal tubular epithelium. It was detected in colorectal carcinomas (CRC) and other nongastrointestinal tumours. The aim of the current study is to investigate the immunohistochemical expression of villin in a subset of primary CRC and determine its relation to tumour differentiation, invasion, nodal metastasis, recurrence, and disease-free survival. Patients and Methods. Paraffin blocks of 93 cases of CRC were retrieved constituting 93 primary CRC and 58 adjacent normal mucosa. Immunohistochemistry was performed using antivillin antibody. The extent (%) of villin immunoexpression was categorised for statistical analysis. Statistical tests were used to determine the association of villin with clinicopathological characteristics: age, sex, tumour location, tumour size, depth of invasion, tumour grade, nodal metastasis, lymphovascular invasion, margin status, recurrence, and survival. Results. Villin immunostaining results showed that villin is downregulated in CRC. Villin has no association with age, sex, tumour location, depth of invasion, nodal metastasis, lymphovascular invasion, margin status, and recurrence. However, villin is expressed in higher rate in CRC less than 5？cm, well- and moderately differentiated CRC. Poor survival was associated with tumour with low villin immunoexpression. Conclusion. Villin was downregulated in CRC. Villin immunoexpression in CRC is associated with better survival, well-differentiated tumours, and small-sized tumours. Villin has no significant association with disease recurrence or nodal metastasis. More in vivo and in vitro studies are required for further elucidation of how villin may be involved in CRC. 1. Introduction Although 70% of colorectal carcinoma (CRC) cases undergo a curative surgery, 50% of surgically cured patients will have at a time an advanced local recurrence or metastases [1]. CRC is a common type of cancer with a considerably poor prognosis and mortality all over the world. The extent of local invasion and tumour metastasis are important factors to determine disease outcome. Distant metastases aggravate treatment failure, and patients will be subjected to palliative treatment. Molecular markers of metastasis are essential to improve treatment protocols [1, 2]. Understanding the molecular pathology underlying CRC needs continuous efforts to discover more prognostic molecules to predict disease outcome and improve therapeutic interventions. The Saudi Arabian National Cancer Registry in 2005 showed
References
[1]
J. W. Huh, H. R. Kim, Y. J. Kim et al., “Expression of standard CD44 in human colorectal carcinoma: association with prognosis,” Pathology International, vol. 59, no. 4, pp. 241–246, 2009.
[2]
T. Kunimura, T. Yoshida, T. Sugiyama, and T. Morohoshi, “The relationships between loss of standard CD44 expression and lymph node, liver metastasis in T3 colorectal carcinoma,” Journal of Gastrointestinal Cancer, vol. 40, no. 3-4, pp. 115–118, 2009.
[3]
H. Al-Eid and S. Arteh, “Cancer Incidence Report Saudi Arabia,” 1–99, 2005.
[4]
R. Athman, D. Louvard, and S. Robine, “The epithelial cell cytoskeleton and intracellular trafficking III. How is villin involved in the actin cytoskeleton dynamics in intestinal cells?” American Journal of Physiology, vol. 283, no. 3, pp. G496–G502, 2002.
[5]
A. Bretscher and K. Weber, “Villin is a major protein of the microvillus cytoskeleton which binds both G and F actin in a calcium-dependent manner,” Cell, vol. 20, no. 3, pp. 839–847, 1980.
[6]
D. Arango, S. Al-Obaidi, D. S. Williams et al., “Villin expression is frequently lost in poorly differentiated colon cancer,” American Journal of Pathology, vol. 180, no. 4, pp. 1509–1521, 2012.
[7]
S. Khurana and S. P. George, “Regulation of cell structure and function by actin-binding proteins: villin's perspective,” FEBS Letters, vol. 582, no. 14, pp. 2128–2139, 2008.
[8]
C. E. Bacchi and A. M. Gown, “Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue,” Laboratory Investigation, vol. 64, no. 3, pp. 418–424, 1991.
[9]
R. Moll, S. Robine, B. Dudouet, and D. Louvard, “Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas,” Virchows Archiv B, vol. 54, no. 3, pp. 155–169, 1987.
[10]
P. J. Zhang, K. R. Harris, B. Alobeid, and J. J. Brooks, “Immunoexpression of villin in neuroendocrine tumors and its diagnostic implications,” Archives of Pathology and Laboratory Medicine, vol. 123, no. 9, pp. 812–816, 1999.
[11]
V. Subramaniam, I. R. Vincent, H. Gardner, E. Chan, H. Dhamko, and S. Jothy, “CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation,” Experimental and Molecular Pathology, vol. 83, no. 2, pp. 207–215, 2007.
[12]
Y. Wang, K. Srinivasan, M. R. Siddiqui, S. P. George, A. Tomar, and S. Khurana, “A novel role for villin in intestinal epithelial cell survival and homeostasis,” The Journal of Biological Chemistry, vol. 283, no. 14, pp. 9454–9464, 2008.
[13]
N. Yoshino, H. Kubokura, S. Yamauchi, Y. Ohaki, K. Koizumi, and K. Shimizu, “Mucinous carcinoma identified as lung metastasis from an early rectal cancer with submucosal invasion by immunohistochemical detection of villin,” Japanese Journal of Thoracic and Cardiovascular Surgery, vol. 54, no. 8, pp. 328–331, 2006.
[14]
R. Athman, M.-I. Fernandez, P. Gounon et al., “Shigella flexneri infection is dependent on villin in the mouse intestine and in primary cultures of intestinal epithelial cells,” Cellular Microbiology, vol. 7, no. 8, pp. 1109–1116, 2005.
[15]
A. Tomar, Y. Wang, N. Kumar et al., “Regulation of cell motility by tyrosine phosphorylated villin,” Molecular Biology of the Cell, vol. 15, no. 11, pp. 4807–4817, 2004.
[16]
N. Al-Muhannadi, N. Ansari, U. Brahmi, and A. A. Satir, “Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material,” Annals of Hepatology, vol. 10, no. 4, pp. 508–515, 2011.
[17]
S. K. Lau, S. Prakash, S. A. Geller, and R. Alsabeh, “Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma,” Human Pathology, vol. 33, no. 12, pp. 1175–1181, 2002.
[18]
H.-J. Grone, K. Weber, U. Helmchen, and M. Osborn, “Villin—a marker of brush border differentiation and cellular origin in human renal cell carcinoma,” American Journal of Pathology, vol. 124, no. 2, pp. 294–302, 1986.
[19]
E. Pringault, M. Arpin, A. Garcia, J. Finidori, and D. Louvard, “A human villin cDNA clone to investigate the differentiation of intestinal and kidney cells in vivo and in culture,” EMBO Journal, vol. 5, no. 12, pp. 3119–3124, 1986.
[20]
Y. Nambu, M. D. Iannettoni, M. B. Orringer, and D. G. Beer, “Unique expression patterns and alterations in the intestinal protein villin in primary and metastatic pulmonary adenocarcinomas,” Molecular Carcinogenesis, vol. 23, pp. 234–242, 1998.
[21]
R. W. Werling, H. Yaziji, C. E. Bacchi, and A. M. Gown, “CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas,” American Journal of Surgical Pathology, vol. 27, no. 3, pp. 303–310, 2003.
[22]
J. Tan, G. Sidhu, M. A. Greco, H. Ballard, and R. Wieczorek, “Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets,” Human Pathology, vol. 29, no. 4, pp. 390–396, 1998.
[23]
A. B. West, C. A. Isaac, J. M. Carboni, J. S. Morrow, M. S. Mooseker, and K. W. Barwick, “Localization of villin, a cytoskeletal protein specific to microvilli, in human ileum and colon and in colonic neoplasms,” Gastroenterology, vol. 94, no. 2, pp. 343–352, 1988.
[24]
S. Kersting, M. Bruewer, G. Schuermann et al., “Antigen transport and cytoskeletal characteristics of a distinct enterocyte population in inflammatory bowel diseases,” American Journal of Pathology, vol. 165, no. 2, pp. 425–437, 2004.
[25]
N. Yamamichi, K.-I. Inada, C. Furukawa et al., “Cdx2 and the Brm-type SWI/SNF complex cooperatively regulate villin expression in gastrointestinal cells,” Experimental Cell Research, vol. 315, no. 10, pp. 1779–1789, 2009.
[26]
R. A. D. Louvard and S. Robine, “Villin enhances hepatocyte growth factor-induced actin cytoskeleton remodeling in epithelial cells,” Molecular Biology of the Cell, vol. 14, no. 11, pp. 4641–4653, 2003.
[27]
S. Khurana, A. Tomar, S. P. George et al., “Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia,” Experimental Cell Research, vol. 314, no. 3, pp. 530–542, 2008.
[28]
A. Tomar, S. George, P. Kansal, Y. Wang, and S. Khurana, “Interaction of phospholipase C-γ1 with villin regulates epithelial cell migration,” The Journal of Biological Chemistry, vol. 281, no. 42, pp. 31972–31986, 2006.
[29]
Y. Wang, A. Tomar, S. P. George, and S. Khurana, “Obligatory role for phospholipase C-gamma(1) in villin-induced epithelial cell migration,” American Journal of Physiology, vol. 292, pp. C1775–C1786, 2007.
